| # | Side effect | Count |
|---|---|---|
| 0 | NAUSEA | 24 |
| 1 | HYPERSENSITIVITY | 20 |
| 2 | HEADACHE | 19 |
| 3 | THERAPEUTIC PRODUCT EFFECT DECREASED | 17 |
| 4 | CONTRAINDICATED PRODUCT ADMINISTERED | 10 |
| 5 | DIARRHOEA | 7 |
| 6 | DRUG INEFFECTIVE | 7 |
| 7 | APPLICATION SITE PAIN | 6 |
| 8 | DEATH | 6 |
| 9 | OFF LABEL USE | 6 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | APPLICATION SITE HYPERTROPHY | 1 | 0.0714 |
| 1 | GALLBLADDER ADENOCARCINOMA | 3 | 0.0423 |
| 2 | HER2 POSITIVE GASTRIC CANCER | 1 | 0.0312 |
| 3 | ACTIVATED PROTEIN C RESISTANCE | 1 | 0.0303 |
| 4 | ACANTHAMOEBA KERATITIS | 1 | 0.0270 |
| 5 | GIANT PAPILLARY CONJUNCTIVITIS | 1 | 0.0200 |
| 6 | FOREIGN BODY IN SKIN OR SUBCUTANEOUS TISSUE | 1 | 0.0145 |
| 7 | BONE MARROW LEUKAEMIC CELL INFILTRATION | 1 | 0.0122 |
| 8 | APPLICATION SITE NODULE | 1 | 0.0073 |
| 9 | APPLICATION SITE WOUND | 1 | 0.0061 |